Literature DB >> 1482946

Evaluating drug prescribing in a large, ambulatory population: application of an embedded expert system.

S M Speedie1, D McNally, S Skarupa, R Michocki, C Rudo, C Metge, F Palumbo, D Knapp.   

Abstract

DUR is a process of problem detection and intervention designed to improve the quality and economy of drug prescribing. Retrospective DUR attempts to detect and address patterns of prescribing that might be indicative of inappropriate therapy. When the process is extended to a largely ambulatory population such as Medicaid beneficiaries, a number of complications are introduced due to the large numbers of patients and sparsity of data. In order to examine the impact of implementing a Medicaid DUR program, we developed a system that would apply screening criteria to prescription claims. It has been used to screen prescribing of groups of two antihypertensive drugs in the 1990 Maryland Medicaid population for 177,409 Medicaid eligible individuals. Potentially significant problems were detected with respect to dosing, duplication of therapeutic agents and drug interactions. The system represents, we believe, a significant improvement in the ability to detect and report prescribing decisions by increasing the specificity of the detection system. By the application of this system to a set of real-world data, we have demonstrated that it is feasible to implement such a system and derive results that are potentially useful in reducing the incidence of inappropriate physician decision-making.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1482946      PMCID: PMC2248057     

Source DB:  PubMed          Journal:  Proc Annu Symp Comput Appl Med Care        ISSN: 0195-4210


  2 in total

Review 1.  Detecting drug interactions: a review of the literature.

Authors:  C A Jankel; S M Speedie
Journal:  DICP       Date:  1990-10

2.  TQuery: a context-sensitive temporal query language.

Authors:  M G Kahn; S Tu; L M Fagan
Journal:  Comput Biomed Res       Date:  1991-10
  2 in total
  1 in total

1.  Physician education and prescribing costs.

Authors:  H J Vosper; T C Frewen
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.